Literature DB >> 22103575

Production of heterologous IgG antibody against Heymann nephritis antigen by injections of immune complexes.

Arpad Z Barabas1, Chad D Cole, Maria Sensen, Rene Lafreniere.   

Abstract

Heterologous IgG antibody (ab) can be produced against Heymann nephritis (HN) antigen (ag) in rabbits by administering it in Freund's complete adjuvant. The developing abs reacted at high titre with rat kidney brush border (BB) regions of the renal proximal tubules in an indirect fluorescence ab test. A single IV injection of the heterologous ab into a susceptible strain of rat resulted in the localization of IgG ab to glomerular fixed ags, producing immune complex glomerular nephritis. The injected ab also reacted with the BB region of the renal proximal tubules. The aim of this experiment was to find out whether heterologous IgG ab against the HN ag can also be produced in recipient rabbits by injecting immune complexes (ICs) composed of a rat kidney tubular preparation [rat kidney fraction 3 (rKF3)] and donor rabbit-derived rabbit anti-rKF3 IgG ab. We found that anti-rKF3 IgG ab--against the BB region of the renal proximal tubules--could be induced in rabbits injected with ICs, and the resulting ab was able to initiate passive HN in rats. This was the first time a pathogenic IgG ab was produced against HN ag in rabbits without the use of adjuvant. Ab responses in recipient rabbits were achieved by ab information transfer. Recipient rabbits injected with the IC produced the same class of immunoglobulin with the same specificity against the target ag rKF3, as was present in the innoculum, namely rabbit anti-rKF3 IgG ab.
© 2011 The Authors. International Journal of Experimental Pathology © 2011 International Journal of Experimental Pathology.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22103575      PMCID: PMC3311017          DOI: 10.1111/j.1365-2613.2011.00792.x

Source DB:  PubMed          Journal:  Int J Exp Pathol        ISSN: 0959-9673            Impact factor:   1.925


  50 in total

1.  A modified vaccination technique for the prevention and treatment of an experimental autoimmune kidney disease.

Authors:  Arpad Zsigmond Barabas; Chad Douglas Cole; Arpad David Barabas; Rene Lafreniere
Journal:  Ann N Y Acad Sci       Date:  2007-09       Impact factor: 5.691

2.  Experimental glomerulonephritis.

Authors:  D J Salant; A V Cybulsky
Journal:  Methods Enzymol       Date:  1988       Impact factor: 1.600

3.  Formation of immune deposits and disease.

Authors:  G Andres; J R Brentjens; P R Caldwell; G Camussi; S Matsuo
Journal:  Lab Invest       Date:  1986-11       Impact factor: 5.662

4.  Induction of an autologous immune-complex glomerulonephritis in the rat by intravenous injection of heterologous anti-rat kidney tubular antibody. I. Production of chronic progressive immune-complex glomerulonephritis.

Authors:  A Z Barabas; R Lannigan
Journal:  Br J Exp Pathol       Date:  1974-02

5.  Auto-immune nephritis in rats.

Authors:  A Z Barabas; R Lannigan
Journal:  J Pathol       Date:  1969-03       Impact factor: 7.996

Review 6.  Membranous nephropathy: recent travels and new roads ahead.

Authors:  Laurence H Beck; David J Salant
Journal:  Kidney Int       Date:  2010-02-24       Impact factor: 10.612

Review 7.  Podocyte antigens and glomerular disease.

Authors:  Pierre Ronco; Hanna Debiec
Journal:  Nephron Exp Nephrol       Date:  2007-08-27

8.  Demonstration of a passive Heymann nephritis-like mechanism in a human kidney transplant.

Authors:  M Zanetti; C Mandet; A Duboust; J Bedrossian; J Bariety
Journal:  Clin Nephrol       Date:  1981-05       Impact factor: 0.975

9.  Effect of reimmunization with Fx1A late in the course of Heymann nephritis.

Authors:  B Noble; J B Van Liew; J R Brentjens; G A Andres
Journal:  Lab Invest       Date:  1982-11       Impact factor: 5.662

10.  Autologous immune complex nephritis induced with renal tubular antigen. I. Identification and isolation of the pathogenetic antigen.

Authors:  T S Edgington; R J Glassock; F J Dixon
Journal:  J Exp Med       Date:  1968-03-01       Impact factor: 14.307

View more
  2 in total

Review 1.  Regaining tolerance to a self-antigen by the modified vaccination technique.

Authors:  Arpad Zsigmond Barabas; Chad Douglas Cole; Rene Lafreniere; Donald Mackay Weir
Journal:  Clin Rev Allergy Immunol       Date:  2013-10       Impact factor: 8.667

2.  Tolerance, loss of tolerance and regaining tolerance to self by immune-mediated events.

Authors:  Arpad Zsigmond Barabas; Chad Douglas Cole; Richard Milton Graeff; Rene Lafreniere; Donald Mackay Weir
Journal:  Immunol Res       Date:  2017-02       Impact factor: 2.829

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.